Neha A Sathe

May 24, 2024 | digitalcommons.library.tmc.edu | Matthew R. Thau |Ted Liu |Neha A Sathe |Grant O'Keefe

IMPORTANCE: It is not clear which severely injured patients with hemorrhagic shock may benefit most from a 1:1:1 vs 1:1:2 (plasma:platelets:red blood cells) resuscitation strategy. Identification of trauma molecular endotypes may reveal subgroups of patients with differential treatment response to various resuscitation strategies.